FDA Adverse Event Death Summary report: N

LC BEAD (100-300UM)

MDR report key: 1574785 · Received January 11, 2010

Report

Report Number
3002124545-2010-00001
Event Type
Death
Date Received
January 11, 2010
Date of Event
December 28, 2009
Report Date
January 4, 2010
Manufacturer
BIOCOMPATIBLES U.K. LIMITED
Product Code
KRD
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT WAS HOSPITALIZED UNTIL THE SCHEDULED LIVER RESECTION IN 2009. THE OPERATION WAS WITHOUT PROBLEM DURING THE LAPAROTOMY, WITHOUT BLEEDING AND WITH HEMODYNAMIC STABILITY. DURING THE FIRST PART OF THE OPERATION, THE PATIENT PRESENTED CARDIAC ELECTROMECHANICAL DISSOCIATION. QUITE SUDDENLY WHEN THE RIGHT PEDICLE WAS ALREADY DIVIDED, CARDIAC FAILURE OCCURRED AND THE PATIENT DIED DUE TO ASYSTOLE WITHOUT RESPONSE TO CARDIAC RESUSCITATION. PRIOR TO THE AUTOPSY RESULTS, THE CAUSE OF THE DEATH WAS ASSUMED TO BE HEART FAILURE. FROM THE POST MORTEM EXAMINATION, THE PATHOLOGIST LATER FOUND THAT THE MOST PROBABLE CAUSE OF DEATH WAS ACUTE PNEUMOMEDIASTINUM. THE WEIGHT OF THE LIVER WAS 3200 G AND LIQUEFACTION OF THE TUMOR WAS EVIDENT. AT THIS TIME IT IS UNK IF THE CAUSE OF DEATH IS RELATED TO THE DEVICE. A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

A FEMALE PATIENT AT A STUDY SITE, TAKING PART IN CLINICAL TRIAL, WHO HAD PREVIOUSLY RECEIVED STUDY TREATMENT (2009) WAS HOSPITALIZED AT THE STUDY SITE HOSPITAL THE FOLLOWING MONTH, DUE TO WORSENING OF HER GENERAL CONDITION. BASED ON REVIEW OF CT SCANS, THE PATIENT WAS INITIALLY DIAGNOSED WITH A LIVER ABSCESS REQUIRING TREATMENT WITH ANTIBIOTIC (TAZOBACTAM). THE INCIDENT IS REGARDED AS A SERIOUS ADVERSE EVENT BECAUSE IT INVOLVED HOSPITALIZATION. AFTER TREATMENT FOR THE SUSPECTED LIVER ABSCESS THE PATIENT UNDERWENT LIVER RESECTION ONE WEEK LATER. THE PATIENT DIED DURING THE OPERATION. FROM THE AUTOPSY THE PATHOLOGIST FOUND THAT THE MOST PROBABLE CAUSE OF DEATH WAS ACUTE PNEUMOMEDIASTINUM. THIS IS A COMPLICATION OF ANAESTHESIA INVOLVING ENDOTRACHEAL INTUBATION (ARTIFICIAL VENTILATION) AND CENTRAL VENOUS CATHETERIZATION, I.E. IT WAS NOT RELATED TO THE SUSPECTED LIVER ABSCESS. THE BLOOD CULTURES WERE NEGATIVE, THIS SUGGESTS THAT THE RADIOLOGIC APPEARANCES POST-TACE REFLECT TUMOUR NECROSIS AND LIQUIFACTION RATHER THAN TRUE ABSCESS FORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LC BEAD (100-300UM) UNK KRD BIOCOMPATIBLES U.K. LIMITED UNK

Patients

Seq Age Sex Outcome Treatment
1 0 YR Death| H LC BEAD WAS LOADED WITH THE DRUG IRINOTECAN IN A| TRIAL. THIS IS NOT AN APPROVED USE IN THE USA.| METASTATIC DISEASE| THE STUDY TREATMENT WAS TRANS ARTERIAL| CHEMOEMBOLIZATION FOR NONRESECTABLE COLO-RECTAL